Spinal Muscular Atrophy Treatment
Latin America · 2 shared keywords
Updated
Reviewed by Chandani Patel
Latin America Narcolepsy Treatment Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Type, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$237.0 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $191.7 Mn | — | — |
| 2025 (base) | $208.6 Mn | +$16.9 Mn | — |
| 2026 (forecast) | $226.9 Mn | +$18.4 Mn | +8.8% |
| 2027 (forecast) | $246.9 Mn | +$20.0 Mn | +18.4% |
| 2028 (forecast) | $268.6 Mn | +$21.7 Mn | +28.8% |
| 2029 (forecast) | $292.3 Mn | +$23.6 Mn | +40.1% |
| 2030 (forecast) | $318.0 Mn | +$25.7 Mn | +52.5% |
| 2031 (forecast) | $346.0 Mn | +$28.0 Mn | +65.9% |
| 2032 (forecast) | $376.4 Mn | +$30.4 Mn | +80.5% |
| 2033 (forecast) | $409.5 Mn | +$33.1 Mn | +96.4% |
| 2034 (forecast) | $445.6 Mn | +$36.0 Mn | +113.6% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $208.6 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $445.6 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 8.8% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Also called | Narcolepsy Therapeutics |
| Segments | Drug class, type and end user (see all) |
| Key players | Jazz Pharmaceuticals, Harmony Biosciences, Avadel Pharmaceuticals, Takeda Pharmaceutical Company Ltd, Axsome Therapeutics (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Narcolepsy treatments reduce daytime sleepiness and sudden muscle weakness in people with this sleep disorder.
Key segments of the narcolepsy Treatment market include drug class (Oxybates, Wake-Promoting Agents and H3 Antagonists) and type (Type 1 and Type 2).
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the narcolepsy Treatment market.
Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the narcolepsy Treatment market strong room to grow.
Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the narcolepsy Treatment market.
The narcolepsy Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medicines are approved by ANVISA (Brazil)[1], ARCSA (Ecuador)[2] and COFEPRIS (Mexico)[3]. How care is paid for in some of these countries: the SUS (Brazil)[4]; public care and IESS (Ecuador)[5]; and IMSS, ISSSTE and IMSS-Bienestar (Mexico)[6].
[1] ANVISA. Checked 14 Nov 2026.
[2] ARCSA. Checked 14 Nov 2026.
[3] COFEPRIS. Checked 14 Nov 2026.
[4] CONITEC. Checked 14 Nov 2026.
[5] Ministry of Public Health of Ecuador. Checked 14 Nov 2026.
[6] Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for narcolepsy Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Latin America.
What doctors and scientists are doing in Narcolepsy Treatment right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Latin America · 2 shared keywords
Latin America
Latin America
Latin America
Latin America
Latin America
Medical Devices · Latin America
Healthcare Services · Latin America
Medical Devices · Latin America
Healthcare Services · Latin America
Digital Health · Latin America
Digital Health · Latin America